March 30, 2021
Kyowa Kirin said on March 29 that it has granted Aevi Genomic Medicine, an affiliate of US drug maker Cerecor, exclusive worldwide rights to develop, manufacture, and commercialize its anti-LIGHT antibody CERC-002 for all indications. CERC-002, which was discovered jointly...read more